Premature cardiovascular disease is common in relatives of patients with premature peripheral atherosclerosis

Archives of Internal Medicine

Volumn 160, Issue 9, 2000, Pages 1343-1348

  Valentine, R James ^a   Verstraete, Richard ^a   Clagett, G Patrick ^a   Cohen, Jonathan C ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; ATHEROSCLEROTIC PLAQUE; CARDIOVASCULAR RISK; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DOPPLER ECHOGRAPHY; FAMILY HISTORY; FEMALE; GENETIC ASSOCIATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; RISK ASSESSMENT;

EID: 0034621497     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.160.9.1343     Document Type: Article

References (33)

1. Hertzer NM. The natural history of peripheral vascular disease: implications for its management. Circulation. 1991;83(suppl I):I12-I19.
2. Valentine RJ. Premature peripheral atherosclerosis. Cardiovasc Surg. 1993;1: 473-480.
3. Valentine RJ, Hansen ME, Myers SI, Chervu A, Clagett GP. The influence of sex and aortic size on late outcome alter aortic revascularization in young adults. J Vasc Surg. 1995;21:296-306.
4. Levy PJ, Hornung CA, Haynes JL, Rush DS. Lower extremity ischemia in young adults younger than forty years of age: a community-wide survey of premature atherosclerotic arterial disease. J Vasc Surg. 1994;19:873-881.
5. Harris LM, Peer R, Curl GR, Pillai L, Upson J, Ricotta JJ. Long term follow up of patients with early atherosclerosis. J Vasc Surg. 1996;23:576-581.
6. McReady RA, Vincent AE, Schwartz RW, Hyde GL, Mattingly SS, Griffin WO Jr. Atherosclerosis in the young: a virulent disease. Surgery. 1984;96:863-868.
7. Valentine RJ, Myers SI, Inman MH, Roberts JR, Clagett GP. Late outcome of amputees with premature atherosclerosis. Surgery. 1996;119:487-493.
8. Evans WE, Hayes JP, Vermillion BD. Atherosclerosis in the younger patients: results of surgical management. Am J Surg. 1987;154:225-229.
9. Krupski WC. The peripheral vascular consequences of smoking. Ann Vasc Surg. 1994;5:291-304.
10. Valentine RJ, Grayburn PA, Vega GL, Grundy SM. Lp(a) lipoprotein is an independent, discriminating risk factor for premature peripheral atherosclerosis among white men. Arch Intern Med. 1994;154:801-806.
11. Boers HJ, Smals AGH, Trijbels FJM, et al. Heterozygosity for homocystinuria in premature peripheral and cerebrovascular occlusive arterial disease. N Engl J Med. 1985;313:709-715.
12. Aronson DC, Onkenhout W, Raben AMTJ, Oudenhoven LFIJ, Brommer EJP, van Bockel JH. Impaired homocysteine metabolism: a risk factor in young adults with atherosclerotic occlusive disease of the leg. Br J Surg. 1994;81:1114-1118.
13. Eldrup-Jorgensen J, Flanigan P, Brace L, et al. Hypercoagulable states and lower limb ischemia in young adults. J Vasc Surg. 1989;9:334-341.
14. Ahn SS, Kalunian K, Rosove M. Postoperative thrombotic complications in patients with the lupus anticoagulant: increased risk after vascular procedures. J Vasc Surg. 1988;7:749-756.
15. Valentine RJ, Kaplan HS, Green R, Jacobsen DW, Myers SI, Clagett GP. Lipoprotein (a), homocysteine, and hypercoagulable states in young men with premature peripheral atherosclerosis: a prospective, controlled analysis. J Vasc Surg. 1996; 23:53-63.
16. Soutar AK. Heart disease: daddies and timebombs. Trends Genet. 1995;11: 425-428.
17. Goldbourt U, Neufeld HN. Genetic aspects of arteriosclerosis. Arteriosclerosis. 1986;6:357-377.
18. National Cholesterol Education Program. Second Report of the Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. JAMA. 1993;269:3015-3023.
19. Guerra R, Wang JP, Grundy SM, Cohen JC. A hepatic lipase (LIPC) allele associated with high plasma concentrations of high density lipoprotein cholesterol. Proc Natl Acad Sci U S A. 1997;94:4532-4537.
20. Cohen JC, Wang Z, Grundy SM, Stoesz MR, Guerra R. Variation at the hepatic lipase and apolipoprotein AI/CIII/AIV loci is a major cause of genetically determined variation in plasma HDL cholesterol levels. J Clin Invest. 1994;94:2377-2384.
21. Wang J, Freeman DJ, Grundy SM, Levine DM, Guerra R, Cohen JC. Linkage between cholesterol 7alpha-hydroxylase and high plasma low-density lipoprotein cholesterol concentrations. J Clin Invest. 1998;101:1283-1291.
22. Kohler TR, Nance DR, Cramer MM, Vandenburghe N, Strandness DE Jr. Duplex scanning for diagnosis of aortoiliac and femoropopliteal disease: a prospective study. Circulation. 1987;76:1074-1080.
23. The Lipid Research Clinics. Population Studies Data Book. Volume I: The Prevalence Study. Washington, DC: US Government Printing Office; July 1979. NIH publication 79-1527.
24. Kannel WB, Doyle JT, Ostfeld AM, et al. Optimal resources for primary prevention of atherosclerotic diseases. Atherosclerosis Study Group. Circulation. 1984; 70:155A-205A.
25. Suurküla M, Fagerberg B, Wendelhag I, et al. Atherosclerotic disease in the femoral artery in hypertensive patients at high cardiovascular risk: the value of ultrasonographic assessment of intima-media thickness and plaque occurrence. Arterioscler Thromb Vasc Biol. 1996;16:971-977.
26. Fowkes FGR, Allan PL, Tsampoulos C, Smith FB, Donnan PT. Validity of duplex scanning in the detection of peripheral arterial disease in the general population. Eur J Vasc Surg. 1992;6:31-35.
27. O'Neal DN, Lewicki J, Ansari MZ, Matthews PG, Best JD. Lipid levels and peripheral vascular disease in diabetic and non-diabetic subjects. Atherosclerosis. 1998;136:1-8.
28. Gallotta G, Iazzetta N, Milan G, Ruocco A, Napoli C, Postiglione A. Prevalence of peripheral arterial disease in an elderly rural population of southern Italy. Gerontology. 1997;43:289-295.
29. Drexel H, Steurer J, Muntwyler J, et al. Predictors of the presence and extent of peripheral arterial occlusive disease. Circulation. 1996;94(suppl II):II-199-II-205.
30. Katsilambros NL, Tsapogas PC, Arvanitis MP, Tritos NA, Alexiou ZP, Rigas KL. Risk factors for lower extremity arterial disease in non-insulin-dependent diabetic persons. Diabet Med. 1996;13:243-246.
31. Fowkes FG, Housley E, Riemersma RA, et al. Smoking, lipids, glucose intolerance, and blood pressure as risk factors for peripheral atherosclerosis compared with ischemic heart disease in the Edinburgh Artery Study. Am J Epidemiol. 1992;135:331-340.
32. Senti M, Nogues X, Pedro-Botet J, Rubies-Prat J, Vidal-Barraquer F. Lipoprotein profile in men with peripheral vascular disease: role of intermediate density lipoproteins and apoprotein E phenotypes. Circulation. 1992;85:30-36.
33. Feussner G, Wagner A, Kohl B, Ziegler R. Clinical features of type III hyperlipo-proteinemia: analysis of 64 patients. Clin Invest. 1993;71:362-366.